In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Some medications are absolutely contraindicated for combined use. For other medi···【more】
Release date:2026-02-05Recommended:223
Cabozantinib is a non-chemotherapy prescription medication classified as a tyros···【more】
Release date:2026-02-05Recommended:293
Patients should take pirfenidone with meals at a fixed time every day to reduce ···【more】
Release date:2026-02-04Recommended:288
The most common side effects of pirfenidone include upper respiratory tract infe···【more】
Release date:2026-02-04Recommended:213
Pirfenidone is an oral antifibrotic medication primarily used for the treatment ···【more】
Release date:2026-02-04Recommended:226
The safety of pirfenidone has been evaluated in more than 1,400 subjects, of who···【more】
Release date:2026-02-04Recommended:305
Nintedanib is a multi-targeted tyrosine kinase inhibitor; it can reduce the acti···【more】
Release date:2026-02-03Recommended:279
In 2019, nintedanib became the first therapy approved by the FDA to slow the rat···【more】
Release date:2026-02-03Recommended:294
Nintedanib is a small-molecule tyrosine kinase inhibitor that binds to growth fa···【more】
Release date:2026-02-03Recommended:240
Nintedanib is indicated for the treatment of diseases that cause scarring and ha···【more】
Release date:2026-02-03Recommended:245
Elacestrant is the world’s first approved oral selective estrogen receptor degra···【more】
Release date:2026-02-02Recommended:263
Before starting elacestrant, discuss any questions or concerns with your medical···【more】
Release date:2026-02-02Recommended:277